Radiopharmaceutical Market Research Report by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
Date: Mar, 2021 | 162 Pages | Report ID: MRI_54419
Radiopharmaceutical Market Research Report by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
ID : MRI54419 | Date : Mar, 2021 | Pages :
162 | Region : Global |
Publisher : MRI
The Radiopharmaceutical market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Radiopharmaceutical market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of xx%% in the forecast period of 2023 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Competitive Landscape and Radiopharmaceutical Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Bayer
Triad Isotopes
Lantheus
GE Healthcare
Mallinckrodt
Eli Lilly
Bracco Imaging
SIEMENS
Navidea
Nordion
IBA Group
Jubilant Pharma
Product Type Coverage (Market Size Forecast, Major Company of Product Type etc.):
SPECT Radioisotopes
PET Radioisotopes
Other Diagnostic Radioisotopes
Therapeutic Radioisotopes
By Application
Oncology
Cardiology
Others
Radiopharmaceutical competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Radiopharmaceutical sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Radiopharmaceutical sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Radiopharmaceutical market presented in the report. This section sheds light on the sales growth of different regional and country-level Radiopharmaceutical markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Radiopharmaceutical market.
By Region:
North America
By Country (US, Canada, Mexico)
By Component
By System
By Application
Western Europe
By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
By Component
By System
By Application
Eastern Europe
By Country (Russia, Turkey, Rest of Eastern Europe)
By Component
By System
By Application
Asia Pacific
By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
By Component
By System
By Application
Middle East
By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
By Component
By System
By Application
Rest of the World
By Region (South America, Africa)
By Component
By System
By Application
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Radiopharmaceutical market for the forecast period 2023 - 2028?
• What are the driving forces in the Radiopharmaceutical market for the forecast period 2023 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Radiopharmaceutical industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Radiopharmaceutical Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Radiopharmaceutical Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.2 America Market Size and Growth
Figure America Radiopharmaceutical Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Radiopharmaceutical Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Radiopharmaceutical Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRadiopharmaceutical Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Radiopharmaceutical Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Radiopharmaceutical Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Radiopharmaceutical Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Radiopharmaceutical Market Forecast and Growth Rate, 2020E-2026F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Radiopharmaceutical Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Radiopharmaceutical Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Radiopharmaceutical Revenue by Type, 2015-2020 (Million USD)
Figure Global Radiopharmaceutical Revenue Share by Type in 2020 (Million USD)
Table Global Radiopharmaceutical Production Volume by Type, 2015-2020 (Volume)
Figure Global Radiopharmaceutical Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Radiopharmaceutical Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Radiopharmaceutical Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Radiopharmaceutical Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Radiopharmaceutical Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Radiopharmaceutical Consumption Value by Region, 2015-2020 (Million USD)
Table Global Radiopharmaceutical Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Radiopharmaceutical Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Radiopharmaceutical Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Radiopharmaceutical Revenue by Type, 2015-2020 (Million USD)
Figure Europe Radiopharmaceutical Revenue Share by Type in 2020 (Million USD)
Table Europe Radiopharmaceutical Production Volume by Type, 2015-2020 (Volume)
Figure Europe Radiopharmaceutical Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Radiopharmaceutical Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Radiopharmaceutical Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Radiopharmaceutical Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Radiopharmaceutical Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Radiopharmaceutical Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Radiopharmaceutical Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Radiopharmaceutical Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Radiopharmaceutical Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Radiopharmaceutical Revenue by Type, 2015-2020 (Million USD)
Figure America Radiopharmaceutical Revenue Share by Type in 2020 (Million USD)
Table America Radiopharmaceutical Production Volume by Type, 2015-2020 (Volume)
Figure America Radiopharmaceutical Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Radiopharmaceutical Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Radiopharmaceutical Consumption Value Share by End-Use in 2020 (Million USD)
Table America Radiopharmaceutical Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Radiopharmaceutical Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Radiopharmaceutical Consumption Value by Region, 2015-2020 (Million USD)
Table America Radiopharmaceutical Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Radiopharmaceutical Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Radiopharmaceutical Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Radiopharmaceutical Revenue by Type, 2015-2020 (Million USD)
Figure Asia Radiopharmaceutical Revenue Share by Type in 2020 (Million USD)
Table Asia Radiopharmaceutical Production Volume by Type, 2015-2020 (Volume)
Figure Asia Radiopharmaceutical Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Radiopharmaceutical Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Radiopharmaceutical Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Radiopharmaceutical Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Radiopharmaceutical Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Radiopharmaceutical Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Radiopharmaceutical Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Radiopharmaceutical Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Radiopharmaceutical Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Radiopharmaceutical Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Radiopharmaceutical Revenue Share by Type in 2020 (Million USD)
Table Oceania Radiopharmaceutical Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Radiopharmaceutical Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Radiopharmaceutical Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Radiopharmaceutical Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Radiopharmaceutical Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Radiopharmaceutical Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Radiopharmaceutical Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Radiopharmaceutical Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Radiopharmaceutical Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Radiopharmaceutical Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Radiopharmaceutical Revenue by Type, 2015-2020 (Million USD)
Figure Africa Radiopharmaceutical Revenue Share by Type in 2020 (Million USD)
Table Africa Radiopharmaceutical Production Volume by Type, 2015-2020 (Volume)
Figure Africa Radiopharmaceutical Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Radiopharmaceutical Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Radiopharmaceutical Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Radiopharmaceutical Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Radiopharmaceutical Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Radiopharmaceutical Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Radiopharmaceutical Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Radiopharmaceutical Production Forecast
Figure Global Radiopharmaceutical Revenue and Growth Rate Forecast 2020E-2026F (Million USD)
Figure Global Radiopharmaceutical Production Volume and Growth Rate Forecast 2020E-2026F (Volume)
8.2 Global Radiopharmaceutical Forecast by Type
Table Global Radiopharmaceutical Revenue by Type, 2020E-2026F (Million USD)
Figure Global Radiopharmaceutical Revenue Share by Type in 2025 (Million USD)
Table Global Radiopharmaceutical Production Volume by Type, 2020E-2026F (Volume)
Figure Global Radiopharmaceutical Production Volume Share by Type in 2025 (Volume)
8.3 Global Radiopharmaceutical Forecast by End-Use (2020E-2026F)
Table Global Radiopharmaceutical Consumption Value by End-Use, 2020E-2026F (Million USD)
Figure Global Radiopharmaceutical Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Radiopharmaceutical Consumption Volume by End-Use, 2020E-2026F (Volume)
8.4 Global Radiopharmaceutical Forecast by Region (2020E-2026F)
Table Global Radiopharmaceutical Consumption Value by Region, 2020E-2026F (Million USD)
Figure Global Radiopharmaceutical Consumption Value Share by Region in 2025 (Million USD)
Table Global Radiopharmaceutical Consumption Volume by Region, 2020E-2026F (Volume)
Figure Global Radiopharmaceutical Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Bayer
9.1.1 Bayer Profile
Table Bayer Overview List
9.1.2 Bayer Products & Services
9.1.3 Bayer Company Dynamics & News
9.1.4 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Triad Isotopes
9.2.1 Triad Isotopes Profile
Table Triad Isotopes Overview List
9.2.2 Triad Isotopes Products & Services
9.2.3 Triad Isotopes Company Dynamics & News
9.2.4 Triad Isotopes Business Operation Conditions
Table Business Operation of Triad Isotopes (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Lantheus
9.3.1 Lantheus Profile
Table Lantheus Overview List
9.3.2 Lantheus Products & Services
9.3.3 Lantheus Company Dynamics & News
9.3.4 Lantheus Business Operation Conditions
Table Business Operation of Lantheus (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 GE Healthcare
9.4.1 GE Healthcare Profile
Table GE Healthcare Overview List
9.4.2 GE Healthcare Products & Services
9.4.3 GE Healthcare Company Dynamics & News
9.4.4 GE Healthcare Business Operation Conditions
Table Business Operation of GE Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Mallinckrodt
9.5.1 Mallinckrodt Profile
Table Mallinckrodt Overview List
9.5.2 Mallinckrodt Products & Services
9.5.3 Mallinckrodt Company Dynamics & News
9.5.4 Mallinckrodt Business Operation Conditions
Table Business Operation of Mallinckrodt (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Eli Lilly
9.6.1 Eli Lilly Profile
Table Eli Lilly Overview List
9.6.2 Eli Lilly Products & Services
9.6.3 Eli Lilly Company Dynamics & News
9.6.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Bracco Imaging
9.7.1 Bracco Imaging Profile
Table Bracco Imaging Overview List
9.7.2 Bracco Imaging Products & Services
9.7.3 Bracco Imaging Company Dynamics & News
9.7.4 Bracco Imaging Business Operation Conditions
Table Business Operation of Bracco Imaging (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 SIEMENS
9.8.1 SIEMENS Profile
Table SIEMENS Overview List
9.8.2 SIEMENS Products & Services
9.8.3 SIEMENS Company Dynamics & News
9.8.4 SIEMENS Business Operation Conditions
Table Business Operation of SIEMENS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Navidea
9.9.1 Navidea Profile
Table Navidea Overview List
9.9.2 Navidea Products & Services
9.9.3 Navidea Company Dynamics & News
9.9.4 Navidea Business Operation Conditions
Table Business Operation of Navidea (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Nordion
9.10.1 Nordion Profile
Table Nordion Overview List
9.10.2 Nordion Products & Services
9.10.3 Nordion Company Dynamics & News
9.10.4 Nordion Business Operation Conditions
Table Business Operation of Nordion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 IBA Group
9.11.1 IBA Group Profile
Table IBA Group Overview List
9.11.2 IBA Group Products & Services
9.11.3 IBA Group Company Dynamics & News
9.11.4 IBA Group Business Operation Conditions
Table Business Operation of IBA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Jubilant Pharma
9.12.1 Jubilant Pharma Profile
Table Jubilant Pharma Overview List
9.12.2 Jubilant Pharma Products & Services
9.12.3 Jubilant Pharma Company Dynamics & News
9.12.4 Jubilant Pharma Business Operation Conditions
Table Business Operation of Jubilant Pharma (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Radiopharmaceutical Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Radiopharmaceutical Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Radiopharmaceutical Sales Volume by Companies, 2015-2020E (Volume)
Table Global Radiopharmaceutical Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Radiopharmaceutical Market Concentration Ratio in 2020E
Figure America Radiopharmaceutical Market Concentration Ratio in 2020E
Figure Asia Radiopharmaceutical Market Concentration Ratio in 2020E
Figure Oceania Radiopharmaceutical Market Concentration Ratio in 2020E
Figure Africa Radiopharmaceutical Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Radiopharmaceutical INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Radiopharmaceutical INDUSTRY SUMMARY & CONCLUSION
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.
